A.Menarini Asia-Pacific Holdings Pte Ltd clinical trials
Acquired by Menarini Group, 2011 · source ↗
The registry lists 5 studies whose lead sponsor is A.Menarini Asia-Pacific Holdings Pte Ltd. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 22, 2025.
Before and after it joined Menarini Group
- First submitted before A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- 0
- First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- 5
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Phase
- Phase 1
- 2
Registry sponsor names on this page
- A.Menarini Asia-Pacific Holdings Pte Ltd5 studies
Something wrong with this grouping? Tell us on the Menarini Group page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Menarini Group studies →
- Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)RecruitingNCT06938516
Sponsor listed in the registry: A.Menarini Asia-Pacific Holdings Pte Ltd · First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer PatientsCompletedNCT03895762
Sponsor listed in the registry: A.Menarini Asia-Pacific Holdings Pte Ltd · First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential HypertensionCompletedNCT03847350
Sponsor listed in the registry: A.Menarini Asia-Pacific Holdings Pte Ltd · First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese PopulationStatus unknownNCT03633760Phase 1
Sponsor listed in the registry: A.Menarini Asia-Pacific Holdings Pte Ltd · First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group
- A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male SubjectsStatus unknownNCT02817932Phase 1
Sponsor listed in the registry: A.Menarini Asia-Pacific Holdings Pte Ltd · First submitted after A.Menarini Asia-Pacific Holdings Pte Ltd became part of Menarini Group